Literature DB >> 8459322

Photosensitizers as virucidal agents.

J North1, H Neyndorff, J G Levy.   

Abstract

The photosensitizer, benzoporphyrin derivative monoacid ring A (BPD-MA) has been studied regarding its ability to destroy enveloped viruses in blood and blood products when activated by light. Its maximum wavelength of absorption (690 nm) has proven useful in terms of activation of the photosensitizer in materials containing red blood cells. Experiments conducted on whole blood of patients infected with the human immunodeficiency virus (HIV) demonstrated that BPD-MA and light could effectively eliminate the virus when treated materials were placed in culture and tested for viral p24, but did not appear to damage blood cells or blood components. Since HIV is largely intracellular in infected individuals, these results were investigated further. We have shown, using flow cytometry, that in HIV-infected blood, BPD-MA and light appear to selectively destroy white cells that bear the interleukin 2 receptor and the DR antigen. These markers are prevalent on activated lymphocytes, and since HIV replicates only in CD4+ T cells which are activated, this finding provides an explanation for the selective killing of HIV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459322     DOI: 10.1016/1011-1344(93)80002-q

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  7 in total

1.  The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency.

Authors:  Adina Lavi; Hana Weitman; Robert T Holmes; Kevin M Smith; Benjamin Ehrenberg
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

3.  Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.

Authors:  Christine Cruz-Oliveira; Andreza F Almeida; João M Freire; Marjolly B Caruso; Maria A Morando; Vivian N S Ferreira; Iranaia Assunção-Miranda; Andre M O Gomes; Miguel A R B Castanho; Andrea T Da Poian
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Inactivation of human immunodeficiency virus type 1 by porphyrins.

Authors:  Andrei N Vzorov; Dabney W Dixon; Jenna S Trommel; Luigi G Marzilli; Richard W Compans
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

6.  A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.

Authors:  Frederic Vigant; Jihye Lee; Axel Hollmann; Lukas B Tanner; Zeynep Akyol Ataman; Tatyana Yun; Guanghou Shui; Hector C Aguilar; Dong Zhang; David Meriwether; Gleyder Roman-Sosa; Lindsey R Robinson; Terry L Juelich; Hubert Buczkowski; Sunwen Chou; Miguel A R B Castanho; Mike C Wolf; Jennifer K Smith; Ashley Banyard; Margaret Kielian; Srinivasa Reddy; Markus R Wenk; Matthias Selke; Nuno C Santos; Alexander N Freiberg; Michael E Jung; Benhur Lee
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

7.  Prevention of poxvirus infection by tetrapyrroles.

Authors:  Avril R M Chen-Collins; Dabney W Dixon; Andrei N Vzorov; Luigi G Marzilli; Richard W Compans
Journal:  BMC Infect Dis       Date:  2003-05-28       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.